H van Veenendaal1,2, H Voogdt-Pruis2,3, D T Ubbink4, C G J M Hilders1,5. 1. Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, the Netherlands. 2. Dutch Association of Oncology Patient Organizations, Utrecht, the Netherlands. 3. EnCorps, Hilversum, the Netherlands. 4. Department of Surgery, Amsterdam University Medical Centre, Amsterdam, the Netherlands. 5. Reinier de Graaf Hospital, Delft, the Netherlands.
Abstract
BACKGROUND: Women with newly diagnosed breast cancer face multiple treatment options. Involving them in a shared decision-making (SDM) process is essential. The aim of this study was to evaluate whether a multilevel implementation programme enhanced the level of SDM behaviour of clinicians observed in consultations. METHODS: This before-after study was conducted in six Dutch hospitals. Patients with breast cancer who were facing a decision on surgery or neoadjuvant systemic treatment between April 2016 and September 2017 were included, and provided informed consent. Audio recordings of consultations made before and after implementation were analysed using the five-item Observing Patient Involvement in Decision-Making (OPTION-5) instrument to assess whether clinicians adopted new behaviour needed for applying SDM. Patients scored their perceived level of SDM, using the nine-item Shared Decision-Making Questionnaire (SDM-Q-9). Hospital, duration of the consultation(s), age, and number of consultations per patient that might influence OPTION-5 scores were investigated using linear regression analysis. RESULTS: Consultations of 139 patients were audiotaped, including 80 before and 59 after implementation. Mean (s.d.) OPTION-5 scores, expressed on a 0-100 scale, increased from 38.3 (15.0) at baseline to 53.2 (14.8) 1 year after implementation (mean difference (MD) 14.9, 95 per cent c.i. 9.9 to 19.9). SDM-Q-9 scores of 105 patients (75.5 per cent) (72 before and 33 after implementation) were high and showed no significant changes (91.3 versus 87.6; MD -3.7, -9.3 to 1.9). The implementation programme had an association with OPTION-5 scores (β = 14.2, P < 0.001), hospital (β = 2.2, P = 0.002), and consultation time (β = 0.2, P < 0.001). CONCLUSION: A multilevel implementation programme supporting SDM in breast cancer care increased the adoption of SDM behaviour of clinicians in consultations.
BACKGROUND: Women with newly diagnosed breast cancer face multiple treatment options. Involving them in a shared decision-making (SDM) process is essential. The aim of this study was to evaluate whether a multilevel implementation programme enhanced the level of SDM behaviour of clinicians observed in consultations. METHODS: This before-after study was conducted in six Dutch hospitals. Patients with breast cancer who were facing a decision on surgery or neoadjuvant systemic treatment between April 2016 and September 2017 were included, and provided informed consent. Audio recordings of consultations made before and after implementation were analysed using the five-item Observing Patient Involvement in Decision-Making (OPTION-5) instrument to assess whether clinicians adopted new behaviour needed for applying SDM. Patients scored their perceived level of SDM, using the nine-item Shared Decision-Making Questionnaire (SDM-Q-9). Hospital, duration of the consultation(s), age, and number of consultations per patient that might influence OPTION-5 scores were investigated using linear regression analysis. RESULTS: Consultations of 139 patients were audiotaped, including 80 before and 59 after implementation. Mean (s.d.) OPTION-5 scores, expressed on a 0-100 scale, increased from 38.3 (15.0) at baseline to 53.2 (14.8) 1 year after implementation (mean difference (MD) 14.9, 95 per cent c.i. 9.9 to 19.9). SDM-Q-9 scores of 105 patients (75.5 per cent) (72 before and 33 after implementation) were high and showed no significant changes (91.3 versus 87.6; MD -3.7, -9.3 to 1.9). The implementation programme had an association with OPTION-5 scores (β = 14.2, P < 0.001), hospital (β = 2.2, P = 0.002), and consultation time (β = 0.2, P < 0.001). CONCLUSION: A multilevel implementation programme supporting SDM in breast cancer care increased the adoption of SDM behaviour of clinicians in consultations.
Authors: Stephen G Henry; Anthony Jerant; Ana-Maria Iosif; Mitchell D Feldman; Camille Cipri; Richard L Kravitz Journal: Patient Educ Couns Date: 2015-03-17
Authors: S Yousuf Zafar; Stewart C Alexander; Kevin P Weinfurt; Kevin A Schulman; Amy P Abernethy Journal: Support Care Cancer Date: 2008-09-19 Impact factor: 3.603
Authors: E A G Joosten; L DeFuentes-Merillas; G H de Weert; T Sensky; C P F van der Staak; C A J de Jong Journal: Psychother Psychosom Date: 2008-04-16 Impact factor: 17.659
Authors: France Légaré; Dawn Stacey; Stéphane Turcotte; Marie-Joëlle Cossi; Jennifer Kryworuchko; Ian D Graham; Anne Lyddiatt; Mary C Politi; Richard Thomson; Glyn Elwyn; Norbert Donner-Banzhoff Journal: Cochrane Database Syst Rev Date: 2014-09-15
Authors: Fabienne E Stubenrouch; Arwen H Pieterse; Rijan Falkenberg; T Katrien B Santema; Anne M Stiggelbout; Trudy van der Weijden; J Annemijn W M Aarts; Dirk T Ubbink Journal: Patient Educ Couns Date: 2015-12-30
Authors: Haske van Veenendaal; Loes J Peters; Dirk T Ubbink; Fabienne E Stubenrouch; Anne M Stiggelbout; Paul Lp Brand; Gerard Vreugdenhil; Carina Gjm Hilders Journal: JMIR Res Protoc Date: 2022-04-06
Authors: Marieke M T Kuijpers; Haske van Veenendaal; Vivian Engelen; Ella Visserman; Eveline A Noteboom; Anne M Stiggelbout; Anne M May; Niek de Wit; Elsken van der Wall; Charles W Helsper Journal: Eur J Cancer Care (Engl) Date: 2021-11-02 Impact factor: 2.328